| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | inhibitory extracellular ligand-gated monoatomic ion channel activity | 8.93e-06 | 8 | 110 | 3 | GO:0005237 | |
| GeneOntologyMolecularFunction | gated channel activity | ASIC2 ASIC1 GLRA3 ANO1 CACHD1 GLRA1 CACNA1I CACNA1H VDAC2 GABRA6 | 1.60e-05 | 334 | 110 | 10 | GO:0022836 |
| GeneOntologyMolecularFunction | low voltage-gated calcium channel activity | 8.99e-05 | 3 | 110 | 2 | GO:0008332 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic anion channel activity | 1.65e-04 | 50 | 110 | 4 | GO:0099095 | |
| GeneOntologyMolecularFunction | sodium channel activity | 1.93e-04 | 52 | 110 | 4 | GO:0005272 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | ASIC2 ASIC1 GLRA3 ANO1 CACHD1 GLRA1 CACNA1I CACNA1H VDAC2 GABRA6 | 2.26e-04 | 459 | 110 | 10 | GO:0005216 |
| GeneOntologyMolecularFunction | monoatomic anion channel activity | 2.64e-04 | 103 | 110 | 5 | GO:0005253 | |
| GeneOntologyMolecularFunction | zinc ion binding | PDE2A CPXM2 ATP13A2 ZRANB3 RNF11 ZFP37 MAP3K1 RNF14 POLR3B DTX4 GLRA1 ADAMTS15 ANKIB1 NOS1 | 3.84e-04 | 891 | 110 | 14 | GO:0008270 |
| GeneOntologyMolecularFunction | voltage-gated sodium channel activity | 3.86e-04 | 26 | 110 | 3 | GO:0005248 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | SLC25A18 ASIC2 ASIC1 GLRA3 ANO1 CACHD1 ATP13A2 GLRA1 CACNA1I CACNA1H DMAC2L VDAC2 GABRA6 | 4.21e-04 | 793 | 110 | 13 | GO:0015075 |
| GeneOntologyMolecularFunction | extracellularly glycine-gated ion channel activity | 4.45e-04 | 6 | 110 | 2 | GO:0016933 | |
| GeneOntologyMolecularFunction | extracellularly glycine-gated chloride channel activity | 4.45e-04 | 6 | 110 | 2 | GO:0016934 | |
| GeneOntologyMolecularFunction | channel activity | ASIC2 ASIC1 GLRA3 ANO1 CACHD1 GLRA1 CACNA1I CACNA1H VDAC2 GABRA6 | 6.48e-04 | 525 | 110 | 10 | GO:0015267 |
| GeneOntologyMolecularFunction | monoatomic ion-gated channel activity | 6.53e-04 | 31 | 110 | 3 | GO:0022839 | |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | ASIC2 ASIC1 GLRA3 ANO1 CACHD1 GLRA1 CACNA1I CACNA1H VDAC2 GABRA6 | 6.57e-04 | 526 | 110 | 10 | GO:0022803 |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity | 7.03e-04 | 193 | 110 | 6 | GO:0015276 | |
| GeneOntologyMolecularFunction | ligand-gated channel activity | 7.82e-04 | 197 | 110 | 6 | GO:0022834 | |
| GeneOntologyMolecularFunction | chloride channel activity | 1.31e-03 | 86 | 110 | 4 | GO:0005254 | |
| GeneOntologyMolecularFunction | complement component C1q complex binding | 1.31e-03 | 10 | 110 | 2 | GO:0001849 | |
| GeneOntologyMolecularFunction | monoatomic anion transmembrane transporter activity | 1.50e-03 | 151 | 110 | 5 | GO:0008509 | |
| GeneOntologyMolecularFunction | clathrin heavy chain binding | 1.91e-03 | 12 | 110 | 2 | GO:0032050 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity | 2.08e-03 | 46 | 110 | 3 | GO:0005245 | |
| GeneOntologyMolecularFunction | MDM2/MDM4 family protein binding | 2.25e-03 | 13 | 110 | 2 | GO:0097371 | |
| GeneOntologyMolecularFunction | glycine binding | 2.62e-03 | 14 | 110 | 2 | GO:0016594 | |
| GeneOntologyMolecularFunction | high voltage-gated calcium channel activity | 2.62e-03 | 14 | 110 | 2 | GO:0008331 | |
| GeneOntologyBiologicalProcess | cell-matrix adhesion | 1.35e-05 | 270 | 109 | 9 | GO:0007160 | |
| GeneOntologyBiologicalProcess | regulation of lysosomal protein catabolic process | 3.05e-05 | 12 | 109 | 3 | GO:1905165 | |
| GeneOntologyBiologicalProcess | regulation of protein catabolic process in the vacuole | 5.01e-05 | 14 | 109 | 3 | GO:1904350 | |
| GeneOntologyCellularComponent | somatodendritic compartment | PCSK5 PDE2A BRINP3 ASIC2 NSF ASIC1 GLRA3 ATP13A2 LDLR NELL2 NRSN2 PTPRK TP63 GLRA1 ARHGAP44 LRP1 ASTN2 C4A CACNA1H C4B BSN NOS1 GABRA6 | 9.99e-08 | 1228 | 111 | 23 | GO:0036477 |
| GeneOntologyCellularComponent | dendrite | PCSK5 PDE2A BRINP3 ASIC2 NSF ASIC1 GLRA3 NELL2 PTPRK TP63 GLRA1 ARHGAP44 LRP1 C4A CACNA1H C4B BSN NOS1 GABRA6 | 1.22e-07 | 858 | 111 | 19 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | PCSK5 PDE2A BRINP3 ASIC2 NSF ASIC1 GLRA3 NELL2 PTPRK TP63 GLRA1 ARHGAP44 LRP1 C4A CACNA1H C4B BSN NOS1 GABRA6 | 1.26e-07 | 860 | 111 | 19 | GO:0097447 |
| GeneOntologyCellularComponent | neuronal cell body | PCSK5 BRINP3 ASIC2 GLRA3 ATP13A2 NELL2 NRSN2 PTPRK GLRA1 LRP1 ASTN2 C4A CACNA1H C4B BSN GABRA6 | 8.53e-06 | 835 | 111 | 16 | GO:0043025 |
| GeneOntologyCellularComponent | cell body | PCSK5 BRINP3 ASIC2 GLRA3 ATP13A2 NELL2 NRSN2 PTPRK GLRA1 LRP1 ASTN2 C4A CACNA1H C4B BSN GABRA6 | 3.16e-05 | 929 | 111 | 16 | GO:0044297 |
| GeneOntologyCellularComponent | postsynaptic specialization | ASIC2 NSF ASIC1 GLRA3 DAPK1 GLRA1 ARHGAP44 LRP1 BSN NOS1 GABRA6 | 7.61e-05 | 503 | 111 | 11 | GO:0099572 |
| GeneOntologyCellularComponent | chloride channel complex | 2.39e-04 | 57 | 111 | 4 | GO:0034707 | |
| GeneOntologyCellularComponent | synaptic membrane | PDE2A ASIC2 ASIC1 GLRA3 ANO1 NRP2 GLRA1 LRP1 CACNA1H BSN GABRA6 | 2.75e-04 | 583 | 111 | 11 | GO:0097060 |
| GeneOntologyCellularComponent | neuron to neuron synapse | 4.75e-04 | 523 | 111 | 10 | GO:0098984 | |
| GeneOntologyCellularComponent | vesicle tethering complex | 5.87e-04 | 72 | 111 | 4 | GO:0099023 | |
| GeneOntologyCellularComponent | postsynaptic specialization membrane | 7.19e-04 | 201 | 111 | 6 | GO:0099634 | |
| GeneOntologyCellularComponent | symbiont cell surface | 7.66e-04 | 8 | 111 | 2 | GO:0106139 | |
| GeneOntologyCellularComponent | cell surface | ASIC1 PPFIA4 TNFRSF14 ANO1 LDLR ITGB6 IGF2R SEMA6D PTPRK CLEC4A GLRA1 ADAMTS15 LRP1 BSN NOTCH2 | 7.84e-04 | 1111 | 111 | 15 | GO:0009986 |
| GeneOntologyCellularComponent | presynapse | VPS11 PDE2A ASIC1 PPFIA4 GLRA3 ANO1 GLRA1 ARHGAP44 CACNA1H BSN NOS1 VDAC2 GABRA6 | 8.45e-04 | 886 | 111 | 13 | GO:0098793 |
| GeneOntologyCellularComponent | monoatomic ion channel complex | 9.29e-04 | 378 | 111 | 8 | GO:0034702 | |
| GeneOntologyCellularComponent | presynaptic active zone | 9.40e-04 | 141 | 111 | 5 | GO:0048786 | |
| GeneOntologyCellularComponent | other organism part | 9.82e-04 | 9 | 111 | 2 | GO:0044217 | |
| GeneOntologyCellularComponent | asymmetric synapse | 1.01e-03 | 477 | 111 | 9 | GO:0032279 | |
| GeneOntologyCellularComponent | perikaryon | 1.23e-03 | 223 | 111 | 6 | GO:0043204 | |
| GeneOntologyCellularComponent | postsynaptic membrane | 1.44e-03 | 405 | 111 | 8 | GO:0045211 | |
| GeneOntologyCellularComponent | clathrin-coated vesicle | 1.68e-03 | 237 | 111 | 6 | GO:0030136 | |
| GeneOntologyCellularComponent | voltage-gated calcium channel complex | 1.87e-03 | 46 | 111 | 3 | GO:0005891 | |
| GeneOntologyCellularComponent | AP-3 adaptor complex | 2.10e-03 | 13 | 111 | 2 | GO:0030123 | |
| GeneOntologyCellularComponent | HOPS complex | 2.44e-03 | 14 | 111 | 2 | GO:0030897 | |
| GeneOntologyCellularComponent | postsynaptic density | 2.81e-03 | 451 | 111 | 8 | GO:0014069 | |
| GeneOntologyCellularComponent | postsynapse | ASIC2 NSF ASIC1 GLRA3 DAPK1 NRP2 GLRA1 ARHGAP44 LRP1 CACNA1H BSN NOS1 GABRA6 | 2.90e-03 | 1018 | 111 | 13 | GO:0098794 |
| GeneOntologyCellularComponent | voltage-gated sodium channel complex | 3.61e-03 | 17 | 111 | 2 | GO:0001518 | |
| GeneOntologyCellularComponent | presynaptic membrane | 3.64e-03 | 277 | 111 | 6 | GO:0042734 | |
| GeneOntologyCellularComponent | glutamatergic synapse | ASIC1 PPFIA4 ANO1 DAPK1 NRP2 C1QL2 ARHGAP44 LRP1 CACNA1H BSN NOS1 | 4.13e-03 | 817 | 111 | 11 | GO:0098978 |
| GeneOntologyCellularComponent | early endosome | 4.15e-03 | 481 | 111 | 8 | GO:0005769 | |
| GeneOntologyCellularComponent | glycinergic synapse | 4.99e-03 | 20 | 111 | 2 | GO:0098690 | |
| GeneOntologyCellularComponent | leading edge membrane | 5.29e-03 | 210 | 111 | 5 | GO:0031256 | |
| GeneOntologyCellularComponent | hippocampal mossy fiber to CA3 synapse | 5.45e-03 | 67 | 111 | 3 | GO:0098686 | |
| Domain | Growth_fac_rcpt_ | 2.84e-08 | 156 | 110 | 10 | IPR009030 | |
| Domain | EGF_2 | ZAN LDLR ITGB6 SNED1 NELL2 FBN2 MEGF8 LRP1 ASTN2 NOTCH2 EPHA1 | 4.70e-07 | 265 | 110 | 11 | PS01186 |
| Domain | EGF | 1.28e-06 | 235 | 110 | 10 | SM00181 | |
| Domain | EGF_Ca-bd_CS | 1.68e-06 | 97 | 110 | 7 | IPR018097 | |
| Domain | EGF_CA | 1.93e-06 | 99 | 110 | 7 | PS01187 | |
| Domain | ASX_HYDROXYL | 2.07e-06 | 100 | 110 | 7 | PS00010 | |
| Domain | EGF_1 | 2.67e-06 | 255 | 110 | 10 | PS00022 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 3.06e-06 | 106 | 110 | 7 | IPR000152 | |
| Domain | EGF-like_CS | 3.29e-06 | 261 | 110 | 10 | IPR013032 | |
| Domain | EGF_CA | 7.78e-06 | 122 | 110 | 7 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 8.66e-06 | 124 | 110 | 7 | IPR001881 | |
| Domain | EGF_3 | 1.05e-05 | 235 | 110 | 9 | PS50026 | |
| Domain | EGF_CA | 1.17e-05 | 86 | 110 | 6 | PF07645 | |
| Domain | EGF-like_dom | 1.66e-05 | 249 | 110 | 9 | IPR000742 | |
| Domain | P53 | 1.03e-04 | 3 | 110 | 2 | PF00870 | |
| Domain | P53 | 1.03e-04 | 3 | 110 | 2 | PS00348 | |
| Domain | p53_DNA-bd | 1.03e-04 | 3 | 110 | 2 | IPR011615 | |
| Domain | p53_tetrameristn | 1.03e-04 | 3 | 110 | 2 | IPR010991 | |
| Domain | VDCC_T_a1 | 1.03e-04 | 3 | 110 | 2 | IPR005445 | |
| Domain | p53_tumour_suppressor | 1.03e-04 | 3 | 110 | 2 | IPR002117 | |
| Domain | - | 1.03e-04 | 3 | 110 | 2 | 4.10.170.10 | |
| Domain | P53_tetramer | 1.03e-04 | 3 | 110 | 2 | PF07710 | |
| Domain | MAM | 1.27e-04 | 17 | 110 | 3 | SM00137 | |
| Domain | MAM | 1.52e-04 | 18 | 110 | 3 | PF00629 | |
| Domain | MAM_dom | 1.52e-04 | 18 | 110 | 3 | IPR000998 | |
| Domain | MAM_2 | 1.52e-04 | 18 | 110 | 3 | PS50060 | |
| Domain | ROC_dom | 2.05e-04 | 4 | 110 | 2 | IPR020859 | |
| Domain | ROC | 2.05e-04 | 4 | 110 | 2 | PS51424 | |
| Domain | Glycine_rcpt_A | 2.05e-04 | 4 | 110 | 2 | IPR008127 | |
| Domain | Galactose-bd-like | 2.34e-04 | 94 | 110 | 5 | IPR008979 | |
| Domain | GABAA/Glycine_rcpt | 3.23e-04 | 23 | 110 | 3 | IPR006028 | |
| Domain | Anaphylatoxin_comp_syst | 3.40e-04 | 5 | 110 | 2 | IPR018081 | |
| Domain | Anaphylatoxn_comp_syst_dom | 3.40e-04 | 5 | 110 | 2 | IPR001840 | |
| Domain | p53/RUNT-type_TF_DNA-bd | 5.08e-04 | 6 | 110 | 2 | IPR012346 | |
| Domain | - | 5.08e-04 | 6 | 110 | 2 | 2.60.40.720 | |
| Domain | hEGF | 5.85e-04 | 28 | 110 | 3 | PF12661 | |
| Domain | ANATO | 7.08e-04 | 7 | 110 | 2 | SM00104 | |
| Domain | ENaC | 7.08e-04 | 7 | 110 | 2 | IPR004724 | |
| Domain | Clathrin | 7.08e-04 | 7 | 110 | 2 | PF00637 | |
| Domain | ANAPHYLATOXIN_2 | 7.08e-04 | 7 | 110 | 2 | PS01178 | |
| Domain | ANAPHYLATOXIN_1 | 7.08e-04 | 7 | 110 | 2 | PS01177 | |
| Domain | ANATO | 7.08e-04 | 7 | 110 | 2 | PF01821 | |
| Domain | CHCR | 7.08e-04 | 7 | 110 | 2 | PS50236 | |
| Domain | Anaphylatoxin/fibulin | 7.08e-04 | 7 | 110 | 2 | IPR000020 | |
| Domain | - | 9.07e-04 | 73 | 110 | 4 | 2.60.120.260 | |
| Domain | Clathrin_H-chain/VPS_repeat | 9.40e-04 | 8 | 110 | 2 | IPR000547 | |
| Domain | MacrogloblnA2_thiol-ester-bond | 9.40e-04 | 8 | 110 | 2 | IPR019565 | |
| Domain | Thiol-ester_cl | 9.40e-04 | 8 | 110 | 2 | PF10569 | |
| Domain | MacrogloblnA2_CS | 9.40e-04 | 8 | 110 | 2 | IPR019742 | |
| Domain | Na+channel_ASC_CS | 9.40e-04 | 8 | 110 | 2 | IPR020903 | |
| Domain | ASC | 1.20e-03 | 9 | 110 | 2 | PF00858 | |
| Domain | ASC | 1.20e-03 | 9 | 110 | 2 | PS01206 | |
| Domain | Na+channel_ASC | 1.20e-03 | 9 | 110 | 2 | IPR001873 | |
| Domain | PSI_integrin | 1.20e-03 | 9 | 110 | 2 | PF17205 | |
| Domain | Integin_beta_N | 1.20e-03 | 9 | 110 | 2 | IPR033760 | |
| Domain | VWFC_1 | 1.23e-03 | 36 | 110 | 3 | PS01208 | |
| Domain | - | 1.35e-03 | 449 | 110 | 9 | 3.30.40.10 | |
| Domain | VWFC_2 | 1.44e-03 | 38 | 110 | 3 | PS50184 | |
| Domain | VWC | 1.44e-03 | 38 | 110 | 3 | SM00214 | |
| Domain | A2M | 1.50e-03 | 10 | 110 | 2 | PF00207 | |
| Domain | A2M_N_2 | 1.50e-03 | 10 | 110 | 2 | IPR011625 | |
| Domain | A2M_comp | 1.50e-03 | 10 | 110 | 2 | IPR011626 | |
| Domain | A2M_recep | 1.50e-03 | 10 | 110 | 2 | PF07677 | |
| Domain | A2M_comp | 1.50e-03 | 10 | 110 | 2 | PF07678 | |
| Domain | A2M_N | 1.50e-03 | 10 | 110 | 2 | PF01835 | |
| Domain | A2M_N | 1.50e-03 | 10 | 110 | 2 | IPR002890 | |
| Domain | A-macroglobulin_rcpt-bd | 1.50e-03 | 10 | 110 | 2 | IPR009048 | |
| Domain | ALPHA_2_MACROGLOBULIN | 1.50e-03 | 10 | 110 | 2 | PS00477 | |
| Domain | E3_UB_ligase_RBR | 1.50e-03 | 10 | 110 | 2 | IPR031127 | |
| Domain | A2M_N_2 | 1.50e-03 | 10 | 110 | 2 | PF07703 | |
| Domain | VDCCAlpha1 | 1.50e-03 | 10 | 110 | 2 | IPR002077 | |
| Domain | Macroglobln_a2 | 1.50e-03 | 10 | 110 | 2 | IPR001599 | |
| Domain | Znf_RING/FYVE/PHD | 1.57e-03 | 459 | 110 | 9 | IPR013083 | |
| Domain | ZF_RING_1 | 1.68e-03 | 291 | 110 | 7 | PS00518 | |
| Domain | SAM | 1.82e-03 | 88 | 110 | 4 | SM00454 | |
| Domain | MACPF | 1.83e-03 | 11 | 110 | 2 | PF01823 | |
| Domain | ZF_RING_2 | 1.93e-03 | 298 | 110 | 7 | PS50089 | |
| Domain | VWF_dom | 1.93e-03 | 42 | 110 | 3 | IPR001007 | |
| Domain | SAM_2 | 2.07e-03 | 43 | 110 | 3 | PF07647 | |
| Domain | MACPF | 2.18e-03 | 12 | 110 | 2 | IPR020864 | |
| Domain | MACPF | 2.18e-03 | 12 | 110 | 2 | SM00457 | |
| Domain | RING | 2.19e-03 | 305 | 110 | 7 | SM00184 | |
| Domain | PSI | 2.21e-03 | 44 | 110 | 3 | IPR016201 | |
| Domain | Neurotransmitter_ion_chnl_CS | 2.36e-03 | 45 | 110 | 3 | IPR018000 | |
| Domain | SAM_DOMAIN | 2.40e-03 | 95 | 110 | 4 | PS50105 | |
| Domain | Neur_chan_memb | 2.51e-03 | 46 | 110 | 3 | PF02932 | |
| Domain | PSI | 2.51e-03 | 46 | 110 | 3 | SM00423 | |
| Domain | SAM | 2.59e-03 | 97 | 110 | 4 | IPR001660 | |
| Domain | Neurotrans-gated_channel_TM | 2.67e-03 | 47 | 110 | 3 | IPR006029 | |
| Domain | - | 2.67e-03 | 47 | 110 | 3 | 2.70.170.10 | |
| Domain | Neur_chan_LBD | 2.67e-03 | 47 | 110 | 3 | PF02931 | |
| Domain | NEUROTR_ION_CHANNEL | 2.67e-03 | 47 | 110 | 3 | PS00236 | |
| Domain | Neur_channel | 2.67e-03 | 47 | 110 | 3 | IPR006201 | |
| Domain | Neur_chan_lig-bd | 2.67e-03 | 47 | 110 | 3 | IPR006202 | |
| Domain | IBR | 2.99e-03 | 14 | 110 | 2 | PF01485 | |
| Domain | IBR | 2.99e-03 | 14 | 110 | 2 | SM00647 | |
| Domain | Ldl_recept_b | 2.99e-03 | 14 | 110 | 2 | PF00058 | |
| Domain | LDLRB | 2.99e-03 | 14 | 110 | 2 | PS51120 | |
| Domain | Znf_RING | 3.18e-03 | 326 | 110 | 7 | IPR001841 | |
| Domain | LY | 3.43e-03 | 15 | 110 | 2 | SM00135 | |
| Pubmed | FASTKD5 MCM7 CACHD1 PHGDH FBN2 IGF2R NUP155 MEGF8 LRP1 TMEM131L ITPRIP VDAC2 | 7.92e-07 | 613 | 113 | 12 | 22268729 | |
| Pubmed | 3.69e-06 | 126 | 113 | 6 | 17897319 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 22737222 | ||
| Pubmed | Deficiency of C4 from donor or recipient mouse fails to prevent renal allograft rejection. | 1.05e-05 | 2 | 113 | 2 | 16565498 | |
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 21307247 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 15998580 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 24256442 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 19062096 | ||
| Pubmed | Characterization of the glycinergic input to bipolar cells of the mouse retina. | 1.05e-05 | 2 | 113 | 2 | 16420443 | |
| Pubmed | Acid-sensing ion channel-1b in the stereocilia of mammalian cochlear hair cells. | 1.05e-05 | 2 | 113 | 2 | 16951561 | |
| Pubmed | Acid-Sensing Ion Channel 1a Contributes to Airway Hyperreactivity in Mice. | 1.05e-05 | 2 | 113 | 2 | 27820848 | |
| Pubmed | Activation of innate and humoral immunity in the peripheral nervous system of ALS transgenic mice. | 1.05e-05 | 2 | 113 | 2 | 19933335 | |
| Pubmed | A T-type calcium channel required for normal function of a mammalian mechanoreceptor. | 1.05e-05 | 2 | 113 | 2 | 12808460 | |
| Pubmed | Structural basis for the C4d.1/C4d.2 serologic allotypes of murine complement component C4. | 1.05e-05 | 2 | 113 | 2 | 2459207 | |
| Pubmed | Antigen-induced B cell apoptosis is independent of complement C4. | 1.05e-05 | 2 | 113 | 2 | 17645767 | |
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 12207352 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 17889283 | ||
| Pubmed | Complement C4A and C4B Gene Copy Number Study in Alzheimer's Disease Patients. | 1.05e-05 | 2 | 113 | 2 | 27758680 | |
| Pubmed | The protein levels of MCM7 and p63 in evaluating lesion severity of cervical disease. | 1.05e-05 | 2 | 113 | 2 | 23318911 | |
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 22387014 | ||
| Pubmed | Tumor-specific p73 up-regulation mediates p63 dependence in squamous cell carcinoma. | 1.05e-05 | 2 | 113 | 2 | 17018588 | |
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 25071191 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 9037075 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 23834509 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 19427358 | ||
| Pubmed | Complement C4 maintains peripheral B-cell tolerance in a myeloid cell dependent manner. | 1.05e-05 | 2 | 113 | 2 | 23749435 | |
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 23918728 | ||
| Pubmed | Conformational stability and activity of p73 require a second helix in the tetramerization domain. | 1.05e-05 | 2 | 113 | 2 | 19763140 | |
| Pubmed | Upregulation of hepatic LDL transport by n-3 fatty acids in LDL receptor knockout mice. | 1.05e-05 | 2 | 113 | 2 | 11971949 | |
| Pubmed | Molecular genetics of androgen-dependent and -independent expression of mouse sex-limited protein. | 1.05e-05 | 2 | 113 | 2 | 3037333 | |
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 11726230 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 4216347 | ||
| Pubmed | Sequence determination of the thiolester site of the fourth component of human complement. | 1.05e-05 | 2 | 113 | 2 | 6950384 | |
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 36786913 | ||
| Pubmed | p73 and p63 regulate the expression of fibroblast growth factor receptor 3. | 1.05e-05 | 2 | 113 | 2 | 20298673 | |
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 8660986 | ||
| Pubmed | Tissue-specific RNA processing for the complement C4 gene transcript in the H-2k mouse strain. | 1.05e-05 | 2 | 113 | 2 | 8428773 | |
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 24638111 | ||
| Pubmed | Transcriptional repression of C4 complement by hepatitis C virus proteins. | 1.05e-05 | 2 | 113 | 2 | 21345967 | |
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 2572548 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 2302180 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 20306292 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 22151770 | ||
| Pubmed | C4d-positive chronic rejection: a frequent entity with a poor outcome. | 1.05e-05 | 2 | 113 | 2 | 18091514 | |
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 29080553 | ||
| Pubmed | LRP: role in vascular wall integrity and protection from atherosclerosis. | 1.05e-05 | 2 | 113 | 2 | 12690199 | |
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 6589636 | ||
| Pubmed | C4 Deficiency is a predisposing factor for Streptococcus pneumoniae-induced autoantibody production. | 1.05e-05 | 2 | 113 | 2 | 25339671 | |
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 17728371 | ||
| Pubmed | Presynaptic release probability is increased in hippocampal neurons from ASIC1 knockout mice. | 1.05e-05 | 2 | 113 | 2 | 18094106 | |
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 6149580 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 6149581 | ||
| Pubmed | ASIC subunit ratio and differential surface trafficking in the brain. | 1.05e-05 | 2 | 113 | 2 | 26746198 | |
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 12115608 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 3542363 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 23135698 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 2387317 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 16908004 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 7365238 | ||
| Pubmed | p63 and p73 do not contribute to p53-mediated lymphoma suppressor activity in vivo. | 1.05e-05 | 2 | 113 | 2 | 16007185 | |
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 7391573 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 17971360 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 14585398 | ||
| Pubmed | Clinical features of patients with homozygous complement C4A or C4B deficiency. | 1.05e-05 | 2 | 113 | 2 | 29928053 | |
| Pubmed | Analysis of C4 and the C4 binding protein in the MRL/lpr mouse. | 1.05e-05 | 2 | 113 | 2 | 17971229 | |
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 6881182 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 14654522 | ||
| Pubmed | Partial C4 deficiency in juvenile idiopathic arthritis patients. | 1.05e-05 | 2 | 113 | 2 | 17921792 | |
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 21880985 | ||
| Pubmed | Amino acid sequence around the thiol and reactive acyl groups of human complement component C4. | 1.05e-05 | 2 | 113 | 2 | 6978711 | |
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 35898513 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 28873507 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 17446929 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 19959465 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 276882 | ||
| Pubmed | Amino acid sequence of a polymorphic segment from fragment C4d of human complement component C4. | 1.05e-05 | 2 | 113 | 2 | 6832377 | |
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 3794341 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 9449704 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 34720879 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 22785613 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 32691186 | ||
| Pubmed | The androgen-dependent C4-Slp gene is driven by a constitutively competent promoter. | 1.05e-05 | 2 | 113 | 2 | 8390682 | |
| Pubmed | Structure and expression of murine fourth complement component (C4) and sex-limited protein (Slp). | 1.05e-05 | 2 | 113 | 2 | 3902619 | |
| Pubmed | Structural polymorphism of murine C4 and its linkage to H-2. | 1.05e-05 | 2 | 113 | 2 | 7373044 | |
| Pubmed | The chemical structure of the C4d fragment of the human complement component C4. | 1.05e-05 | 2 | 113 | 2 | 3696167 | |
| Pubmed | Restriction fragment length polymorphism of the murine C4 and Slp genes: two C4 groups. | 1.05e-05 | 2 | 113 | 2 | 1357031 | |
| Pubmed | Structural comparison of human C4A3 and C4B1 after proteolytic activation by C1s. | 1.05e-05 | 2 | 113 | 2 | 16098595 | |
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 17505534 | ||
| Pubmed | Increased frequency of C4B*Q0 alleles in patients with Henoch-Schönlein purpura. | 1.05e-05 | 2 | 113 | 2 | 15787745 | |
| Pubmed | p63 and p73 expression in extrahepatic bile duct carcinoma and their clinical significance. | 1.05e-05 | 2 | 113 | 2 | 17385050 | |
| Pubmed | Death-associated protein kinase-mediated cell death modulated by interaction with DANGER. | 1.05e-05 | 2 | 113 | 2 | 20053891 | |
| Pubmed | p63 mediates survival in squamous cell carcinoma by suppression of p73-dependent apoptosis. | 1.05e-05 | 2 | 113 | 2 | 16413471 | |
| Pubmed | Protons are a neurotransmitter that regulates synaptic plasticity in the lateral amygdala. | 1.05e-05 | 2 | 113 | 2 | 24889629 | |
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 30026462 | ||
| Pubmed | The role of p53 protein family in gastrointestinal malignancies. | 1.05e-05 | 2 | 113 | 2 | 16557273 | |
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 6559257 | ||
| Pubmed | 1.05e-05 | 2 | 113 | 2 | 21486794 | ||
| Pubmed | Complement C4 Is Reduced in iPSC-Derived Astrocytes of Autism Spectrum Disorder Subjects. | 1.05e-05 | 2 | 113 | 2 | 34299197 | |
| Pubmed | Assessment of complement C4 gene copy number using the paralog ratio test. | 1.05e-05 | 2 | 113 | 2 | 20506482 | |
| Pubmed | Diagnostic role of DOG1 and p63 immunohistochemistry in salivary gland carcinomas. | 1.05e-05 | 2 | 113 | 2 | 26464669 | |
| Interaction | FBXO2 interactions | PCSK5 CACHD1 SNED1 NELL2 FBN2 IGF2R MEGF8 PTPRK TMEM131L NOTCH2 EPHA1 | 1.30e-05 | 411 | 108 | 11 | int:FBXO2 |
| Interaction | ZFP41 interactions | 1.35e-05 | 57 | 108 | 5 | int:ZFP41 | |
| GeneFamily | Acid sensing ion channel subunits | 1.78e-04 | 5 | 77 | 2 | 290 | |
| GeneFamily | Glycine receptors | 1.78e-04 | 5 | 77 | 2 | 868 | |
| GeneFamily | C3 and PZP like, alpha-2-macroglobulin domain containing | 6.32e-04 | 9 | 77 | 2 | 1234 | |
| GeneFamily | Low density lipoprotein receptors | 1.35e-03 | 13 | 77 | 2 | 634 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.08e-08 | 199 | 112 | 8 | 19a97e27a4758e794ce7246d295e112b47931a48 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.63e-07 | 186 | 112 | 7 | 3dae539cce15fcf2b1b32e981d7febe94c03c600 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L5-6_LAMP5_SFTA3_(Lamp5_Lhx6_2)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.98e-07 | 188 | 112 | 7 | 8268574584e5fb869a6cb8bbd7135cd7454a6a25 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Macroglial-oligodendrocyte_precursor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.98e-07 | 188 | 112 | 7 | a244fcd092d5bd544e503366b1439b0fbc1ee00e | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Macroglial-Oligodendrocyte_progenitor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.98e-07 | 188 | 112 | 7 | c8530c9ff98666c64a94683261af4288cb790a7e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.16e-07 | 189 | 112 | 7 | e059be2965cca70ff5576df055d0af1775b76e00 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L5-6_LAMP5_SFTA3_(Lamp5_Lhx6_2)|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.34e-07 | 190 | 112 | 7 | 59720dfe9de1b980807644536c919d2a02ba69dd | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Macroglial-oligodendrocyte_precursor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.34e-07 | 190 | 112 | 7 | 9b825b2586c7b173ff27fcf2abc5860faf50984a | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Macroglial-Oligodendrocyte_progenitor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.34e-07 | 190 | 112 | 7 | d146af1926474328a7c822bc140c4dda66e1bbfb | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.29e-07 | 199 | 112 | 7 | 333056c2abe9724efeab542c0365fcfe4eff8f18 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.29e-07 | 199 | 112 | 7 | e60ecbb8fa7bcd3e2ce7d78f6efb2cfd1fd77698 | |
| ToppCell | PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.22e-06 | 150 | 112 | 6 | cc8361bdcaa16ab6a0d6a3684690d709bc42ff3b | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Neuronal-interneuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.40e-06 | 175 | 112 | 6 | 65571d775d26a40e979dbf290a8e4320c0d9fb3f | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.56e-06 | 181 | 112 | 6 | 6a6bd8e020cb0929b6ecdcb55d467ad24fecfaf0 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.77e-06 | 182 | 112 | 6 | 14a117c5e50db31ee1b2cf4df4d133451fd6d55f | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Epithelial-neuroepithelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.77e-06 | 182 | 112 | 6 | 9174fb0b7ed8f721a5c513e41fd80476a9f34332 | |
| ToppCell | COPD-Epithelial-ATII|World / Disease state, Lineage and Cell class | 6.98e-06 | 183 | 112 | 6 | 8e9aab4eeec2e282c2cab9bfca6dbf40d660c7b9 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.98e-06 | 183 | 112 | 6 | cfae90c309622b5d499e62a3a8a8b9746478d28d | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.98e-06 | 183 | 112 | 6 | 92fbd83a9d13ee91065cbd479fb298f1fd564568 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.20e-06 | 184 | 112 | 6 | d33de57876817050b294f2ecb0a4eb0634cfa7f0 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.90e-06 | 187 | 112 | 6 | fa01a61bfd13feb033ba1e35cf513707b1bff8c8 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.39e-06 | 189 | 112 | 6 | 1ecf9911ff82e0ca0f0c101b735d3b1f3b339d57 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L5-6_LAMP5_SFTA3_(Lamp5_Lhx6_2)|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.39e-06 | 189 | 112 | 6 | 222e67d3fd106c43b0cae6538dddeaa7be1f759f | |
| ToppCell | facs-Skin-Anagen|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.39e-06 | 189 | 112 | 6 | adbfc723130079b4caf551f66d2aee86fab1903c | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.65e-06 | 190 | 112 | 6 | 8aea807a2bcf0b653b4de6202b6ecb0f0683cc2e | |
| ToppCell | Control-Stromal_mesenchymal|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.91e-06 | 191 | 112 | 6 | 14057205ddb9b4bbc582d1358d13cf36d979a61b | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_B1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 8.91e-06 | 191 | 112 | 6 | 39ef8e1d7cc3ebb11717e8a55501515e3b72b177 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.91e-06 | 191 | 112 | 6 | ca5669bd6f4a17471acae3eb229f845cc2e08efa | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|World / Lineage, Cell type, age group and donor | 8.91e-06 | 191 | 112 | 6 | d3733c8c4bda70c4390e5601fdda6188a64be944 | |
| ToppCell | E17.5-Epithelial-epithelial_progenitor_cell-epi_progenitor|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 8.91e-06 | 191 | 112 | 6 | 328b98d371a7d6b6a1adc61ded05a3e52a839894 | |
| ToppCell | Children_(3_yrs)-Immune-monocyte-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.46e-06 | 193 | 112 | 6 | 58e1930a1d80ad3729ab9604ac8ebf7308232a3d | |
| ToppCell | E16.5-samps-Epithelial-Alveolar_epithelial_precursor|E16.5-samps / Age Group, Lineage, Cell class and subclass | 9.46e-06 | 193 | 112 | 6 | c1817ad675b9f9d2d3436c8b9646edf89f0d4c82 | |
| ToppCell | E16.5-samps-Epithelial|E16.5-samps / Age Group, Lineage, Cell class and subclass | 9.46e-06 | 193 | 112 | 6 | 1cb5a1cffa2b4a3bfecca16b791c1992edeb237d | |
| ToppCell | Control-Epithelial|Control / Disease state, Lineage and Cell class | 1.00e-05 | 195 | 112 | 6 | 1798c3b89b1b5ff4f5777d2b9f52dc81cdad28fa | |
| ToppCell | droplet-Tongue-TONGUE|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-05 | 196 | 112 | 6 | 44a30b1a5f3d8c845e5f3bd17d8102a7449f555b | |
| ToppCell | COVID-19-kidney-TAL|kidney / Disease (COVID-19 only), tissue and cell type | 1.03e-05 | 196 | 112 | 6 | 04f5eb206ed3016a737609a3ebac0c1fcabb94ef | |
| ToppCell | droplet-Tongue-TONGUE-1m|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-05 | 196 | 112 | 6 | 9935bdb10789e8cfc922dca526ca3bf8317fe270 | |
| ToppCell | background-Endothelial_cells|background / Sample and Cell Type and Tumor Cluster (all cells) | 1.03e-05 | 196 | 112 | 6 | e6fb0bfab1779ec64a8c35d01519eaafbf62e977 | |
| ToppCell | droplet-Tongue-TONGUE-1m-Epithelial|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-05 | 196 | 112 | 6 | a85f5f1e6acc798e9e02b1a21e0ffe87a323c333 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.09e-05 | 198 | 112 | 6 | 5374b0e98d669f36a0571d3c006c7bd5e3c8e87f | |
| ToppCell | Bronchial-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.13e-05 | 199 | 112 | 6 | 5f7da3eab58ace6cddb3179a415cd839d5767958 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal-Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.13e-05 | 199 | 112 | 6 | 94a7867e800df352731796de8c24cba133c29622 | |
| ToppCell | Parenchymal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.13e-05 | 199 | 112 | 6 | 5cea0d9e261903e0eaad60c28a07dff72ce65027 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.16e-05 | 200 | 112 | 6 | ad777683adeb2ce45ade570386235e311fa7ea2d | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Pericyte-Pericyte_2|Control_saline / Treatment groups by lineage, cell group, cell type | 1.16e-05 | 200 | 112 | 6 | bc8949eb34482aca166c4602ff6ab876cb4c2c3c | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1-6_VIP_PENK|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.13e-05 | 152 | 112 | 5 | 88a810d41edb5a917c23cb5ba5a387227e1312cb | |
| ToppCell | wk_15-18-Mesenchymal-Myofibro_&_SMC-Myofibro_2|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 4.82e-05 | 157 | 112 | 5 | b9d04ee417c0d8ea0801d10f1c54e138587009fd | |
| ToppCell | Striatum-Neuronal-Inhibitory|Striatum / BrainAtlas - Mouse McCarroll V32 | 4.82e-05 | 157 | 112 | 5 | c41ff3fe9de7187575114febfe9bd8733366fb8a | |
| ToppCell | E16.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.59e-05 | 162 | 112 | 5 | 34b4cd3d2258f88dfbd6d32abd1db87aff8a6b6f | |
| ToppCell | E16.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.76e-05 | 163 | 112 | 5 | 56b8668dbf06faa6866ec71f29b92907b73f074d | |
| ToppCell | Striatum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Th-Inhibitory_Neuron.Gad1Gad2-Th.Trh_(Th+_interneuron)|Striatum / BrainAtlas - Mouse McCarroll V32 | 6.31e-05 | 85 | 112 | 4 | 67336aa7ec02b64595ce7d5222d43cead92eb52e | |
| ToppCell | Striatum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Th|Striatum / BrainAtlas - Mouse McCarroll V32 | 6.31e-05 | 85 | 112 | 4 | a7a5d82924cd4a41ab87b1abf13143635882a4b2 | |
| ToppCell | Striatum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Th-Inhibitory_Neuron.Gad1Gad2-Th.Trh_(Th+_interneuron)-|Striatum / BrainAtlas - Mouse McCarroll V32 | 6.31e-05 | 85 | 112 | 4 | 86c5d71b66ff55c44d2d457865dda72e07e5ec53 | |
| ToppCell | facs-Trachea-24m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l15|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.46e-05 | 167 | 112 | 5 | 55c3c68af269fcf40f2b080ae4489523609ad388 | |
| ToppCell | droplet-Pancreas-Exocrine-24m-Epithelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.65e-05 | 168 | 112 | 5 | 100ab6d36592b61f4db9f8cb90c48afac016d679 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_SEMA6D|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.83e-05 | 169 | 112 | 5 | 319cba07263bf41fcbcbfecd117f91b729394241 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.83e-05 | 169 | 112 | 5 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D231|Adult / Lineage, Cell type, age group and donor | 7.03e-05 | 170 | 112 | 5 | 269dee5abca9f6aa079f116f0d8f1d198604d9d4 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-5_RORB_HSPB3|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.03e-05 | 170 | 112 | 5 | 985c6c9e3c593ed0628a481f06c2c91b2ab5d746 | |
| ToppCell | E16.5-samps-Epithelial-Alveolar_epithelial_precursor-Uncommitted_AE_cell|E16.5-samps / Age Group, Lineage, Cell class and subclass | 7.03e-05 | 170 | 112 | 5 | 5a64e05c263df915085988d881808221e2c0f2e2 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal--glomerular_mesenchymal_cell-Renin-positive_Juxtaglomerular_Granular_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.03e-05 | 170 | 112 | 5 | 99dd734c0972a40d5381e8e2d96bdaa31f6d06e6 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal--glomerular_mesenchymal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.03e-05 | 170 | 112 | 5 | 3a14eeae221b8bb0bd0dadcb8e7a603431240a1e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.03e-05 | 170 | 112 | 5 | cdb6fad277f284c3fd5a6f45672a8edc24715882 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.63e-05 | 173 | 112 | 5 | e1378201b15ffb98e196ac39fe3ee4b4078953bd | |
| ToppCell | facs-Large_Intestine-Proximal-3m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.63e-05 | 173 | 112 | 5 | 99532bb768ee35fed939a377acb5215d3f8904bd | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_SEMA6D|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.63e-05 | 173 | 112 | 5 | 9a2d42f8d9cb834856522661d524abb91c4637c5 | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.06e-05 | 175 | 112 | 5 | 9d082ba0e350162aa6e71b668be074b12a27c7ab | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.06e-05 | 175 | 112 | 5 | f641f34b52aec5d047430a6f9d026e915da6c11d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.06e-05 | 175 | 112 | 5 | 284fdc7a9d303636a637041846850d19d114861a | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Macroglial-Oligodendrocyte_progenitor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.28e-05 | 176 | 112 | 5 | ef0ff02897104e938c8a632357d8f1a6f014e68a | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Ptprt_Pkp2|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 8.28e-05 | 176 | 112 | 5 | 05ec715439f2eb1696f5d8855da0dd1dd70effd0 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Macroglial-oligodendrocyte_precursor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.28e-05 | 176 | 112 | 5 | da0983929fa682a68e536c298a2d7add188b7563 | |
| ToppCell | Hippocampus|World / BrainAtlas - Mouse McCarroll V32 | 8.28e-05 | 176 | 112 | 5 | f120a703f6d2f2d5f55eae1aea2e6382a485828f | |
| ToppCell | facs-Heart-LA-24m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.50e-05 | 177 | 112 | 5 | 32fecefba1a55e1f418c9a055236fa11175c692d | |
| ToppCell | facs-Heart-LA-24m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.50e-05 | 177 | 112 | 5 | 1b153fbfe1323dc589de4af73a52149ea5ce6763 | |
| ToppCell | Control-Epithelial_alveolar-AT_1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.73e-05 | 178 | 112 | 5 | aa7d43c655df493f1330a5001efaa484e4a19f69 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.73e-05 | 178 | 112 | 5 | 24e8c62060455159235985f456af0c5023a7f3f5 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Macrophage_Dendritic|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.73e-05 | 178 | 112 | 5 | 4f1cc954d4d9b5b2b75a4cf995ba81e2ada27084 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.96e-05 | 179 | 112 | 5 | 8766a5a066091879f521acfc612abf563ff78808 | |
| ToppCell | facs-Lung-EPCAM-3m-Epithelial-Alveolar_Epithelial_Type_1|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.96e-05 | 179 | 112 | 5 | 88dbec952507d84b85b08165eec80df99ed1e736 | |
| ToppCell | facs-Lung-EPCAM-3m-Epithelial-type_I_pneumocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.96e-05 | 179 | 112 | 5 | daf8189a22786171e2b629261cf720736aa4ebdb | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.96e-05 | 179 | 112 | 5 | cb38b54261a7af5ee3347e64c8aa880a77ed0763 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Mesenchymal-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.96e-05 | 179 | 112 | 5 | e880c507f11ce75d104593a4ca29f0295f8125e8 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Macroglial-oligodendrocyte_precursor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.20e-05 | 180 | 112 | 5 | fa819df81fca95c2cc602fede635cb03e3f35fad | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Macroglial-Oligodendrocyte_progenitor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.20e-05 | 180 | 112 | 5 | 907cd510fd2e21532ce04ba687e8894f7af71f27 | |
| ToppCell | facs-Lung-18m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.44e-05 | 181 | 112 | 5 | b0fff0defba9aea6fba36e378b05a59986e2573a | |
| ToppCell | COPD-Epithelial-Basal|World / Disease state, Lineage and Cell class | 9.44e-05 | 181 | 112 | 5 | 6d8a886b4afe729f8a05b9c0f4ea9375de735da4 | |
| ToppCell | facs-Lung-18m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.44e-05 | 181 | 112 | 5 | cc77ac0e223e012767222e45c5dcadc246d1aa7c | |
| ToppCell | facs-Lung-18m-Endothelial-lymphatic_endothelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.44e-05 | 181 | 112 | 5 | ecd52f33841f4e9d946a4edad0d58da9b0cc5ffa | |
| ToppCell | facs-Limb_Muscle-Muscle_Diaphragm|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.69e-05 | 182 | 112 | 5 | 81c394959414173016426961478f670cd822f8b3 | |
| ToppCell | facs-Limb_Muscle-Muscle_Diaphragm-18m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.69e-05 | 182 | 112 | 5 | 41a7543c8b703441ff6ac2307faffe5f798b2c41 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.69e-05 | 182 | 112 | 5 | a8cc56f32efe180e8fb5d69dbe606a794b3db700 | |
| ToppCell | Control-Epithelial-Basal|Control / Disease state, Lineage and Cell class | 9.69e-05 | 182 | 112 | 5 | caddd0a52f0234ea6a916186ffaf2454cdcd80ee | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L5-6_LAMP5_SFTA3_(Lamp5_Lhx6_2)|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.94e-05 | 183 | 112 | 5 | f8b636391f752e379a5c5575fd898bdf0907a3b8 | |
| ToppCell | COPD-Epithelial-Basal|COPD / Disease state, Lineage and Cell class | 9.94e-05 | 183 | 112 | 5 | 0f760e393edc91009bf6c7e02eeac039a1dfb4ed | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L5-6_LAMP5_SFTA3_(Lamp5_Lhx6_2)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.02e-04 | 184 | 112 | 5 | e2de27cee3ea80f9b7a9a7884ceceeaa67b3214a | |
| ToppCell | COVID-19-Epithelial_cells-AT2|COVID-19 / group, cell type (main and fine annotations) | 1.02e-04 | 184 | 112 | 5 | 369b82f793deab672204558ae4e112cfa5aa9ccc | |
| ToppCell | droplet-Lung-30m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.02e-04 | 184 | 112 | 5 | f506d0ee48f39d6f59f19554217dfdf0987cc405 | |
| ToppCell | droplet-Lung-30m-Endothelial-arterial_endothelial|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.02e-04 | 184 | 112 | 5 | 8bcb1c4bc8ffef74338cdade926a94711de93c64 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex_-18m-Macroglial-Oligodendrocyte_progenitor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-04 | 184 | 112 | 5 | 278a7ed764c326450cb70e69ed2175980eaf5fe0 | |
| Computational | Neurotransmitter (GABA) receptor. | 8.70e-05 | 15 | 64 | 3 | MODULE_215 | |
| Disease | body weight | PCSK5 BRINP3 ZBTB38 HIVEP2 NEXMIF WDR70 ANO1 GCKR THSD7B NBAS FBN2 SEMA6D GLRA1 DLEU7 ASTN2 UNC79 | 1.79e-05 | 1261 | 110 | 16 | EFO_0004338 |
| Disease | neuropilin-2 measurement | 4.12e-05 | 3 | 110 | 2 | EFO_0801836 | |
| Disease | neuropathy, type 2 diabetes mellitus | 4.12e-05 | 3 | 110 | 2 | EFO_0004149, MONDO_0005148 | |
| Disease | Gingival bleeding | 8.22e-05 | 4 | 110 | 2 | HP_0000225 | |
| Disease | testicular cancer (implicated_via_orthology) | 1.37e-04 | 5 | 110 | 2 | DOID:2998 (implicated_via_orthology) | |
| Disease | quality of life during menstruation measurement | 1.37e-04 | 5 | 110 | 2 | EFO_0009366 | |
| Disease | Global developmental delay | 1.45e-04 | 133 | 110 | 5 | C0557874 | |
| Disease | temporal lobe epilepsy (biomarker_via_orthology) | 2.10e-04 | 31 | 110 | 3 | DOID:3328 (biomarker_via_orthology) | |
| Disease | Crohn's disease | 2.53e-04 | 441 | 110 | 8 | EFO_0000384 | |
| Disease | Common Migraine | 2.86e-04 | 7 | 110 | 2 | C0338480 | |
| Disease | Parkinson Disease | 2.93e-04 | 85 | 110 | 4 | C0030567 | |
| Disease | cholelithiasis | 3.35e-04 | 88 | 110 | 4 | EFO_0004799 | |
| Disease | Developmental delay (disorder) | 3.57e-04 | 37 | 110 | 3 | C0424605 | |
| Disease | triacylglycerol 50:3 measurement | 4.18e-04 | 39 | 110 | 3 | EFO_0010410 | |
| Disease | multiple system atrophy | 4.50e-04 | 40 | 110 | 3 | EFO_1001050 | |
| Disease | colonic neoplasm | 4.85e-04 | 41 | 110 | 3 | EFO_0004288 | |
| Disease | sciatic neuropathy (biomarker_via_orthology) | 5.24e-04 | 99 | 110 | 4 | DOID:11446 (biomarker_via_orthology) | |
| Disease | interleukin 9 measurement | 5.58e-04 | 43 | 110 | 3 | EFO_0008192 | |
| Disease | subiculum volume | 5.58e-04 | 43 | 110 | 3 | EFO_0009399 | |
| Disease | triglycerides in large LDL measurement | 5.58e-04 | 43 | 110 | 3 | EFO_0022319 | |
| Disease | glucose measurement | 5.68e-04 | 380 | 110 | 7 | EFO_0004468 | |
| Disease | linoleic acid measurement | 6.76e-04 | 186 | 110 | 5 | EFO_0006807 | |
| Disease | body surface area | 6.90e-04 | 643 | 110 | 9 | EFO_0022196 | |
| Disease | phospholipids in medium LDL measurement | 8.20e-04 | 49 | 110 | 3 | EFO_0022183 | |
| Disease | cerebral white matter volume change measurement | 8.87e-04 | 12 | 110 | 2 | EFO_0021499 | |
| Disease | total lipids in LDL measurement | 9.75e-04 | 52 | 110 | 3 | EFO_0022308 | |
| Disease | intelligence, self reported educational attainment | 9.81e-04 | 117 | 110 | 4 | EFO_0004337, EFO_0004784 | |
| Disease | cardiomyopathy (biomarker_via_orthology) | 1.05e-03 | 13 | 110 | 2 | DOID:0050700 (biomarker_via_orthology) | |
| Disease | Congenital pontocerebellar hypoplasia | 1.05e-03 | 13 | 110 | 2 | C0266468 | |
| Disease | total lipids in medium VLDL | 1.09e-03 | 54 | 110 | 3 | EFO_0022153 | |
| Disease | asthma, Eczema, allergic rhinitis | 1.11e-03 | 121 | 110 | 4 | EFO_0005854, HP_0000964, MONDO_0004979 | |
| Disease | triglycerides in LDL measurement | 1.21e-03 | 56 | 110 | 3 | EFO_0022320 | |
| Disease | nephroblastoma (is_implicated_in) | 1.22e-03 | 14 | 110 | 2 | DOID:2154 (is_implicated_in) | |
| Disease | total lipids in large LDL | 1.27e-03 | 57 | 110 | 3 | EFO_0022163 | |
| Disease | cholesterol in large LDL measurement | 1.27e-03 | 57 | 110 | 3 | EFO_0021901 | |
| Disease | smoking status measurement | ZNF438 CPXM2 ASIC2 NSF THSD7B XYLT1 SEMA6D PTPRK ITPRIP UNC79 VDAC2 GABRA6 | 1.31e-03 | 1160 | 110 | 12 | EFO_0006527 |
| Disease | triglycerides in IDL measurement | 1.34e-03 | 58 | 110 | 3 | EFO_0022149 | |
| Disease | YKL40 measurement | 1.40e-03 | 15 | 110 | 2 | EFO_0004869 | |
| Disease | phospholipids in VLDL measurement | 1.41e-03 | 59 | 110 | 3 | EFO_0022301 | |
| Disease | phospholipids in small LDL measurement | 1.41e-03 | 59 | 110 | 3 | EFO_0022297 | |
| Disease | total lipids in VLDL measurement | 1.48e-03 | 60 | 110 | 3 | EFO_0022314 | |
| Disease | inflammatory bowel disease | 1.49e-03 | 449 | 110 | 7 | EFO_0003767 | |
| Disease | total blood protein measurement | 1.49e-03 | 449 | 110 | 7 | EFO_0004536 | |
| Disease | free cholesterol in VLDL measurement | 1.55e-03 | 61 | 110 | 3 | EFO_0022276 | |
| Disease | response to antineoplastic agent, response to antimicrotubule agent | 1.60e-03 | 16 | 110 | 2 | EFO_0005260, GO_0097327 | |
| Disease | coffee consumption, cups of coffee per day measurement | 1.60e-03 | 16 | 110 | 2 | EFO_0004330, EFO_0006782 | |
| Disease | Pontoneocerebellar hypoplasia | 1.60e-03 | 16 | 110 | 2 | cv:C1261175 | |
| Disease | migraine without aura, susceptibility to, 4 | 1.60e-03 | 16 | 110 | 2 | MONDO_0011847 | |
| Disease | triglycerides in medium LDL measurement | 1.62e-03 | 62 | 110 | 3 | EFO_0022322 | |
| Disease | cholesterol in large VLDL measurement | 1.86e-03 | 65 | 110 | 3 | EFO_0021902 | |
| Disease | cholesterol in very large VLDL measurement | 1.86e-03 | 65 | 110 | 3 | EFO_0022230 | |
| Disease | total lipids in small VLDL | 2.03e-03 | 67 | 110 | 3 | EFO_0022148 | |
| Disease | FEV/FEC ratio | ZNF438 PCSK5 CLDN18 HIVEP2 ANO1 MCM7 ATP13A2 MAP3K1 NRP2 NELL2 LRP1 ASTN2 | 2.11e-03 | 1228 | 110 | 12 | EFO_0004713 |
| Disease | Abdominal Aortic Aneurysm | 2.12e-03 | 68 | 110 | 3 | EFO_0004214 | |
| Disease | renal cell carcinoma (is_implicated_in) | 2.21e-03 | 69 | 110 | 3 | DOID:4450 (is_implicated_in) | |
| Disease | Congenital hernia of foramen of Morgagni | 2.26e-03 | 19 | 110 | 2 | C0265699 | |
| Disease | Congenital hernia of foramen of Bochdalek | 2.26e-03 | 19 | 110 | 2 | C0265700 | |
| Disease | response to supplemental oxygen | 2.26e-03 | 19 | 110 | 2 | EFO_0009796 | |
| Disease | hemorrhoid | 2.27e-03 | 147 | 110 | 4 | EFO_0009552 | |
| Disease | serum non-albumin protein measurement | 2.37e-03 | 361 | 110 | 6 | EFO_0004568 | |
| Disease | blood aluminium measurement | 2.50e-03 | 20 | 110 | 2 | EFO_0007575 | |
| Disease | major depressive disorder | 2.75e-03 | 155 | 110 | 4 | MONDO_0002009 | |
| Disease | Congenital diaphragmatic hernia | 2.76e-03 | 21 | 110 | 2 | C0235833 | |
| Disease | Antimigraine preparation use measurement | 2.76e-03 | 21 | 110 | 2 | EFO_0009939 | |
| Disease | Parkinson's disease (implicated_via_orthology) | 2.88e-03 | 157 | 110 | 4 | DOID:14330 (implicated_via_orthology) | |
| Disease | Autistic Disorder | 3.00e-03 | 261 | 110 | 5 | C0004352 | |
| Disease | triacylglycerol 48:2 measurement | 3.03e-03 | 22 | 110 | 2 | EFO_0010405 | |
| Disease | triacylglycerol 54:6 measurement | 3.03e-03 | 22 | 110 | 2 | EFO_0010424 | |
| Disease | Lung diseases | 3.13e-03 | 78 | 110 | 3 | C0024115 | |
| Disease | Lung Neoplasms | 3.20e-03 | 265 | 110 | 5 | C0024121 | |
| Disease | Malignant neoplasm of lung | 3.25e-03 | 266 | 110 | 5 | C0242379 | |
| Disease | epilepsy (implicated_via_orthology) | 3.29e-03 | 163 | 110 | 4 | DOID:1826 (implicated_via_orthology) | |
| Disease | Immunologic Deficiency Syndromes | 3.31e-03 | 23 | 110 | 2 | C0021051 | |
| Disease | clinical and behavioural ideal cardiovascular health | 3.31e-03 | 23 | 110 | 2 | EFO_0007654 | |
| Disease | insulin sensitivity measurement | 3.31e-03 | 23 | 110 | 2 | EFO_0004471 | |
| Disease | complex trait | 3.52e-03 | 271 | 110 | 5 | EFO_0010578 | |
| Disease | Hodgkins lymphoma | 3.60e-03 | 82 | 110 | 3 | EFO_0000183 | |
| Disease | eosinophil count | HIVEP2 FERMT1 TNFRSF14 ANO1 WBP2NL C16orf96 CACHD1 GCKR ITGB6 FAM193A CACNA1H NOTCH2 VDAC2 | 3.63e-03 | 1488 | 110 | 13 | EFO_0004842 |
| Disease | diastolic blood pressure, systolic blood pressure | 3.66e-03 | 670 | 110 | 8 | EFO_0006335, EFO_0006336 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RMDMDTPHCLTCPQQ | 286 | P21709 | |
| PGCENVSVRSRSMMF | 751 | P53355 | |
| FPECNCPSMDIQAME | 286 | Q76B58 | |
| VCMCNNETPNRVMLD | 541 | Q8TD16 | |
| CESMERSCPGNYPMQ | 101 | Q3SY05 | |
| RCCQDGVTRLPMMRS | 701 | P0C0L5 | |
| MDMNPECFVSPRCAK | 511 | Q9BQL6 | |
| QDCCTIPPSMMEFDG | 126 | Q5VU97 | |
| CMCSISVFEDPVDMP | 336 | Q9P2G1 | |
| SRCDSDLCEMNAGMP | 1646 | Q6UB98 | |
| MSPCSCPQCVLVMSV | 186 | Q9Y2E6 | |
| SEQRLTCADQMMPFG | 6 | Q99766 | |
| HMLSSRLSMPDCPNC | 191 | P78312 | |
| ILAMVCGSQMSCPLT | 446 | O75129 | |
| GMADVGTMCDPKRSC | 331 | Q8TE58 | |
| NCRMVHMPGDAPFCT | 321 | Q16515 | |
| NGSICMRMEILGCPL | 281 | Q8N436 | |
| MCAEVGPALCRGMER | 1 | Q2M1V0 | |
| CPMDLKNFPMDVQTC | 171 | O75311 | |
| MAPPCGDMENLLCAT | 276 | Q8IWB1 | |
| MPCLNGGTCAVASNM | 1311 | Q04721 | |
| MTSAQCPALACVMSP | 1 | O60309 | |
| CRENTMCVNTPGSFM | 451 | Q99435 | |
| SSTAMQCVPSDGCAM | 11 | Q6ZVW7 | |
| TRPAQDLLMSVCMNC | 381 | Q8N201 | |
| DRGPCTLAQMAMRSA | 106 | Q6UYE1 | |
| NTEKGLMEVQRMCCP | 1566 | Q38SD2 | |
| VPMSRLCNGVQDCMD | 86 | Q07954 | |
| PTWMRMSQGVCCNLE | 556 | O75335 | |
| GMRPESQLACCDMVY | 1891 | Q9UPA5 | |
| LIMNPRGSCMANEKC | 1441 | Q92824 | |
| MGPRCECGEDMLSTD | 486 | P18564 | |
| CGFLNSFIMCPQTMQ | 151 | A6NFC9 | |
| SFIMCPQTMQLSRCG | 156 | A6NFC9 | |
| NCPETFTPDMRCIMG | 356 | Q8NCN5 | |
| SMLGCELQAMLCVPV | 321 | O00408 | |
| GCRVTDAPCSNMLGM | 426 | O60462 | |
| TMDNMTGLCRPVCAQ | 2211 | Q7Z7M0 | |
| MAGRSMQAARCPTDE | 1 | P46459 | |
| CPMRLVNFPMDGHAC | 156 | Q16445 | |
| GCATMDENIPSMEMC | 356 | Q5XXA6 | |
| MMPSCNRSCSCSRGP | 1 | Q9GZP1 | |
| ACLGDPGSPMMCQLQ | 216 | Q6PEW0 | |
| PQMPSARECCSIVCM | 56 | Q9Y6Z4 | |
| MMHCSACSENPPAGI | 1141 | A2RRP1 | |
| MPLIMCPSQECQTNR | 201 | P33993 | |
| QCNCMMGVFPPISRA | 101 | O75694 | |
| GMNPCPMVLVFGCRQ | 1276 | P29475 | |
| GLSAPFVAGQMDCCM | 181 | Q14397 | |
| MDCCMNNTAVFLPVL | 191 | Q14397 | |
| RCEMTSAPPLLCQMT | 761 | Q5K4E3 | |
| FMCNSSCVGGMNRRP | 256 | O15350 | |
| LAMDCGVNCFMLDPA | 176 | P09467 | |
| FMCNSSCVGGMNRRP | 306 | Q9H3D4 | |
| LMPCDAALVAGECMV | 326 | Q9NQ11 | |
| MAGLCPAACMQTPRM | 681 | Q7L8L6 | |
| MGTCRMICDPYTAAP | 26 | Q7Z5L3 | |
| KCISCDRPVEMMTGP | 911 | A6NNT2 | |
| IMCVSMRGTICNPGP | 76 | Q8NCG7 | |
| GAGMCQVVVTCPMEM | 111 | Q9H1K4 | |
| VGCMPLCSMDVRLPS | 131 | P29279 | |
| LNCVTLGMYQPCDDM | 91 | Q9P0X4 | |
| MATMLEGRCQTQPRS | 1 | Q6NUI2 | |
| PQMMDEVGRILCNLC | 701 | Q92771 | |
| VTMCMRCQEPFNALT | 461 | Q7Z6J4 | |
| IGTFMCICPPGMARR | 2316 | P35556 | |
| MLNCVTLGMFRPCED | 111 | O95180 | |
| CQMFVGMRSPKLEEC | 41 | W5XKT8 | |
| MMCIACRGLAPEETN | 191 | P56856 | |
| PEMVCIDSCGRANGM | 176 | Q9NQT5 | |
| IMEMAKNCNVDPRGC | 226 | Q7L3B6 | |
| RCCQDGVTRLPMMRS | 701 | P0C0L4 | |
| GTMAERCSETSCPVM | 76 | Q70IA8 | |
| MLRYGPIQVECMSCS | 1291 | Q15262 | |
| TSMSPQLCALMLGVC | 151 | Q8NGR9 | |
| QMCPICLLGMLDEES | 441 | Q13233 | |
| MRSFTCPSCMEPVDA | 131 | Q9Y3C5 | |
| LCPQRGMCKSVFVME | 786 | Q9Y2M0 | |
| MFNVCGTMPVCGTIL | 966 | P11717 | |
| MRHNQMCCETPPTVT | 1 | Q5MJ70 | |
| CLMLNPPNFCEMDGQ | 96 | P03973 | |
| SECSMKEGIQTCMFP | 1071 | A2VDJ0 | |
| MSALNGDCLMQPSRT | 131 | Q5QGS0 | |
| CPMDLKNFPMDVQTC | 166 | P23415 | |
| ADLRIVMCAMCGDPF | 776 | Q13017 | |
| QPEELLCFSCQMCMA | 4111 | Q9P2P6 | |
| MTCGPQGNRTMCEVG | 826 | Q96J65 | |
| PIEACVTMLLECGMQ | 271 | Q17R89 | |
| GLLCEFEITAMPCNM | 496 | Q8TER0 | |
| FEITAMPCNMNTQCP | 501 | Q8TER0 | |
| ENCNCRMVHMPGDAP | 321 | P78348 | |
| NCLGPQRSVCEMMKI | 221 | Q9UMR7 | |
| TQNAEMRPLGCCMIL | 126 | P60900 | |
| LPVMQEPGCTMGICS | 316 | Q9UBS8 | |
| AMDICATGPTACPVM | 916 | Q86Y38 | |
| DCPTCLPENRKVMDM | 856 | Q9H270 | |
| SASGLPTMFPMTDCC | 416 | Q9NW82 | |
| AGSVCLLMQVSMPCV | 96 | O00442 | |
| VITGEGNMCTPQMPC | 156 | Q6ICG8 | |
| MATHGQTCARPMCIP | 1 | P45880 | |
| MPFCDSGICPDIIMN | 916 | Q9NW08 | |
| CMVQCSQLSTGEPMI | 481 | Q5VIR6 | |
| ECLPMPSMNSAAQFC | 821 | P49754 | |
| CQMCDPAMGLRASRN | 96 | Q92956 | |
| CGMIMCLARQIPQAT | 111 | O43175 | |
| DSPLGLCQSECMEMS | 886 | Q8NAP3 | |
| ETQSCSLMCPNECVM | 1116 | Q9C0I4 | |
| CMDEECMLPSEPSSS | 2021 | P31629 | |
| EMVFVCGTNAFNPMC | 131 | Q8NFY4 | |
| CNQASMGCQAPKPDM | 66 | Q9Y6Q3 | |
| CSKAPAQTQMCPQMS | 146 | Q7Z4V0 | |
| MDQPSGRSFMQVLCE | 1 | Q5QJ74 | |
| CEMCETPQGSAVMQI | 641 | Q5FWF4 | |
| MIASVPGCGTAAMEC | 2306 | Q9P2D8 | |
| CMMQTCSFDIPNDLC | 206 | Q9Y493 | |
| CACPDGMLLARDMRS | 696 | P01130 |